Valid for Submission
D09.3 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of thyroid and other endocrine glands. The code D09.3 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D09.3 might also be used to specify conditions or terms like carcinoma in situ of adrenal cortex, carcinoma in situ of adrenal gland, carcinoma in situ of adrenal medulla, carcinoma in situ of craniopharyngeal duct, carcinoma in situ of endocrine gland , carcinoma in situ of multiple endocrine glands, etc.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: adrenal ; adrenal capsule ; adrenal cortex ; adrenal gland ; adrenal medulla ; cortex ; cortex adrenal ; etc
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D09.3:
Type 1 ExcludesType 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoma in situ of adrenal cortex
- Carcinoma in situ of adrenal gland
- Carcinoma in situ of adrenal medulla
- Carcinoma in situ of craniopharyngeal duct
- Carcinoma in situ of endocrine gland
- Carcinoma in situ of multiple endocrine glands
- Carcinoma in situ of parathyroid gland
- Carcinoma in situ of pineal gland
- Carcinoma in situ of pituitary gland
- Carcinoma in situ of thyroglossal duct
- Carcinoma in situ of thyroid gland
- Neoplasm of adrenal cortex
- Neoplasm of craniopharyngeal duct
- Neoplasm of parathyroid gland
- Neoplasm of thyroglossal duct
- Primary malignant neoplasm of thymus
- Primary squamous cell carcinoma of thymus
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|826||MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC||17||5.0368|
|827||MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC||17||2.4976|
|828||MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC||17||1.6777|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D09.3 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D09.3 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Table of Neoplasms
The code D09.3 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
|»craniopharyngeal (duct) (pouch)||C75.2||C79.89||D09.3||D35.3||D44.4||D49.7|
|»endocrine gland NEC||C75.9||C79.89||D09.3||D35.9||D44.9||D49.7|
|»endocrine gland NEC|
|»gland, glandular (lymphatic) (system) [See Also: Neoplasm, lymph gland]||C75.9||C79.89||D09.3||D35.9||D44.9||D49.7|
|»gland, glandular (lymphatic) (system) [See Also: Neoplasm, lymph gland]|
|»pineal (body) (gland)||C75.3||C79.89||D09.3||D35.4||D44.5||D49.7|
|»pituitary (body) (fossa) (gland) (lobe)||C75.1||C79.89||D09.3||D35.2||D44.3||D49.7|
Information for Patients
Your thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It makes hormones that help the body work normally. There are several types of cancer of the thyroid gland. You are at greater risk if you
- Are between ages 25 and 65
- Are a woman
- Are Asian
- Have a family member who has had thyroid disease
- Have had radiation treatments to your head or neck
You should see a doctor if you have a lump or swelling in your neck. Doctors use a physical exam, thyroid tests, other blood and imaging tests, and a biopsy to diagnose thyroid cancer. Treatment depends on the type of cancer you have and how far the cancer has spread. Many patients receive a combination of treatments. They may include surgery, radioactive iodine, hormone treatment, radiation therapy, chemotherapy, or targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Thyroid Cancer—Patient Version Learn about thyroid cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]